EG

GlaxoSmithKline plc (EGS38171C012)

EGX

Currency in EGP
333.50
+19.49 (+6.21%)

Closed

Sep 3, 2026

Day's Range

314.01
353.88

52 wk Range

55.10
609.00

Profile - EGS38171C012 - GlaxoSmithKline plc

Profile

Mic Code

XCAI

Employees

0


GlaxoSmithKline plc is a global healthcare company that engages in the research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products. Known for its innovative treatments in the areas of infectious diseases, oncology, and respiratory health, the company plays a crucial role in advancing healthcare solutions worldwide. GSK's diverse product portfolio includes well-known brands and life-saving medicines, impacting sectors such as pharmaceuticals and consumer health globally. With a focus on addressing urgent public health challenges, GlaxoSmithKline collaborates with governments, NGOs, and other industry players to enhance access to healthcare in both developed and emerging markets. The company’s significant research investment in vaccines and chronic condition treatments underscores its commitment to transforming the way diseases are managed, contributing substantially to global health advancements. Headquartered in London, GSK's influence is reflected in its presence across numerous international markets, making it a pivotal player in the life sciences industry.

Profile Details

Type

Common Stock

Country

Egypt

Cross Listings - EGS38171C012 - GlaxoSmithKline plc

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.